Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2 - Test2 - elhamkhani - TriplyDB

Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2

Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2

http://www.wikidata.org/entity/Q28284294

about

PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis Opposite Interplay between PPAR Gamma and Canonical Wnt/Beta-Catenin Pathway in Amyotrophic Lateral Sclerosis Thiazolidinediones and Edema: Recent Advances in the Pathogenesis of Thiazolidinediones-Induced Renal Sodium Retention The case for intraocular delivery of PPAR agonists in the treatment of diabetic retinopathy A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation Alzheimer Disease: Crosstalk between the Canonical Wnt/Beta-Catenin Pathway and PPARs Alpha and Gamma Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells The organization, promoter analysis, and expression of the human PPARgamma gene Peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition of human hepatocellular carcinoma L-764406 is a partial agonist of human peroxisome proliferator-activated receptor gamma. The role of Cys313 in ligand binding Pharmacological peroxisome proliferator-activated receptorgamma ligands: emerging clinical indications beyond diabetes.Peroxisome proliferator-activated receptor gamma1 (PPAR-gamma1) as a major PPAR in a tissue in which estrogen induces peroxisome proliferation.Troglitazone suppresses telomerase activity independently of PPARgamma in estrogen-receptor negative breast cancer cells A Dominant-Negative PPARgamma Mutant Promotes Cell Cycle Progression and Cell Growth in Vascular Smooth Muscle Cells Thermodynamics in Gliomas: Interactions between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma Gene expression profiling of subcutaneous adipose tissue in morbid obesity using a focused microarray: distinct expression of cell-cycle- and differentiation-related genes RNA-seq identified a super-long intergenic transcript functioning in adipogenesis Association of DNA Methylation Levels with Tissue-specific Expression of Adipogenic and Lipogenic Genes in Longissimus dorsi Muscle of Korean Cattle.Association between the peroxisome proliferator-activated receptor gamma Pro12Ala variant and haplotype and pancreatic cancer in a high-risk cohort of smokers: a pilot study Gastrointestinal Cytoprotection by PPARγ Ligands.Genetics of leptin and obesity: a HuGE review.15-Lipoxygenase-2 gene regulation by its product 15-(S)-hydroxyeicosatetraenoic acid through a negative feedback mechanism that involves peroxisome proliferator-activated receptor gamma.Effects of low doses of pioglitazone on resting-state functional connectivity in conscious rat brain.Over-representation of PPARgamma sequence variants in sporadic cases of glioblastoma multiforme: preliminary evidence for common low penetrance modifiers for brain tumour risk in the general population.The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-gamma.Peroxisome proliferator-activated receptor-gamma: therapeutic target for diseases beyond diabetes: quo vadis?Peroxisome proliferator-activated receptors: mediators of phthalate ester-induced effects in the male reproductive tract?Nuclear Receptors in Regulation of Mouse ES Cell Pluripotency and Differentiation The role of peroxisome proliferator-activated receptors in the development and physiology of gametes and preimplantation embryos Investigational PPAR-gamma agonists for the treatment of Type 2 diabetes.Drug insight: thiazolidinediones and diabetic nephropathy--relevance to renoprotection.Nonsteroidal anti-inflammatory drugs in Parkinson's disease: possible involvement of quinone formation.PPARgamma Agonists: Potential as Therapeutics for Neovascular Retinopathies Peroxisome proliferator-activated receptor-gamma ligands as bone turnover modulators.Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.Fat targets for skeletal health New PPARG mutation leads to lipodystrophy and loss of protein function that is partially restored by a synthetic ligand.Macrophage peroxisome proliferator activated receptor gamma as a therapeutic target to combat Type 2 diabetes.The Potential Applications of Peroxisome Proliferator-Activated Receptor delta Ligands in Assisted Reproductive Technology Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinoma

P2860

Q24553314-51951390-2EF1-4F28-9B3B-2313508A93A1 Q26742196-4F8537D0-0523-41B6-9E03-89BC092A7A56 Q26851905-65017D16-B8B0-4D8F-BEB4-89CC5C6577F3 Q26865958-A916305D-C0DD-4B39-91D5-9F6DD62BEDB9 Q27618352-FF6D69BD-10A9-44D7-AF97-4AB0BAE40BE9 Q28075617-B23E8AB7-7091-40BE-BC8B-BFBDC4795A53 Q28214426-98D03A78-5B1F-4E2F-B1CB-79995030F3BE Q28244071-F6F77938-0590-4CA6-9B3F-0E88BB49B251 Q28366616-C57B7E9C-510E-430F-8BEA-D1A6DAF96E45 Q28371591-25E93D0B-B288-4BB5-99D2-8DAEDA6747E2 Q30977623-0CDB75E5-E7ED-469F-903A-B5051CD08B04 Q32019780-198A6EAE-A6E0-4188-A042-25409A99852C Q33637896-BFBFBF4B-58C6-4264-87A3-080A06E9DE2C Q33724886-474A9CFB-00BB-484B-A67D-27087F20E45F Q33748280-E892745E-ED47-414C-B742-0675BBAB6679 Q33779549-60E5A333-DC35-43CF-8F1B-FBE4BD5388EA Q33953038-B65C0144-FF50-4B81-A67A-2D05BAC377B4 Q34113175-A971C99E-FD37-4E5F-A727-28DCB33BD692 Q34122003-63A9CE04-6DB0-4BDF-8616-B45E7844F409 Q34159427-262CB249-74A5-43BA-B851-7DF9886E4E65 Q34428366-0E548591-AA1B-4718-B4AB-FD0223B85F74 Q34523177-98A7E540-75DE-46CD-8876-B8D01F2593E9 Q35073600-DF964ED9-5F98-42D9-A115-3A3FFA5D8CEB Q35434987-A728EBB5-3046-47C9-8655-EA39DC192954 Q35676497-7CB6DA85-889E-4A89-98C2-17167AE8E7C4 Q35688221-09C3A654-2E94-4C05-8BBB-49ADF51D7828 Q35924008-F7FE9A11-F364-4F2F-8DBD-F0A0E0361BBE Q36445376-C1C25CF5-1D9C-4DA8-BE11-C753D0C59013 Q36494472-7A1EA560-B32F-462D-B567-95A4B0596373 Q36512559-E64BE981-352D-4CFE-AD0A-9942D881FDF3 Q36577073-9D559F97-5A49-477B-83B7-F43C6FD0D938 Q36607332-EBD6C3D3-2FDA-4885-8492-8CED7A0903EB Q36676571-ABD82C7F-CDA2-4803-8488-166EEEEC9489 Q36715753-C12FFA41-63CE-4F08-932B-F6E10A895C4C Q36830195-82D216F0-10FB-45EB-88E7-2C0F8F05B0DF Q36866334-9F24B24C-64F9-44DB-BCEE-6D2E99E7A44B Q37004608-65245855-BD15-4D2F-ADC1-158BE9F3CC4A Q37008855-9DD041D7-FD25-44F5-94B3-0783518188ED Q37015993-D7B74F5E-9669-449E-898E-21B97C9A73F5 Q37031730-14A908A1-6D17-4AE8-B603-0656EF7CD711

P2860

Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2

http://www.wikidata.org/entity/Q28284294

description

1996 nî lūn-bûn

@nan

1996 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Molecular cloning, expression ...... receptors gamma 1 and gamma 2

@ast

Molecular cloning, expression ...... receptors gamma 1 and gamma 2

@en

Molecular cloning, expression ...... receptors gamma 1 and gamma 2

@nl

type

label

Molecular cloning, expression ...... receptors gamma 1 and gamma 2

@ast

Molecular cloning, expression ...... receptors gamma 1 and gamma 2

@en

Molecular cloning, expression ...... receptors gamma 1 and gamma 2

@nl

prefLabel

Molecular cloning, expression ...... receptors gamma 1 and gamma 2

@ast

Molecular cloning, expression ...... receptors gamma 1 and gamma 2

@en

Molecular cloning, expression ...... receptors gamma 1 and gamma 2

@nl

P1433

Q28284294-C3C7F08A-6225-4631-9397-706591A25F7E

P1476

Q28284294-862E00B2-EBD2-4A86-9ACA-C1C24A11832F

P2093

Q28284294-279BBCFD-820C-40ED-B847-F1A1AA17E1DF

Q28284294-2960315F-5901-40B8-A49C-839347850485

Q28284294-3AAEFCF0-795E-4088-9AE8-9C272CC1DF4C

Q28284294-8AEC53D2-A866-43AA-8ADC-BDF7DF3C28E3

Q28284294-A58050D1-D979-4A8B-BAE5-90A2B7F72D47

Q28284294-D4B0CC93-AE7D-4D85-9885-B109D72C9A38

Q28284294-EDFCA717-AF7B-4FA5-B514-8C06CBF5E4FE

P304

Q28284294-A04E36BC-C439-4614-B996-6FE618653425

P31

Q28284294-DAE9C68D-35B8-4E2C-BB03-0B8E9184C51A

P3181

Q28284294-9C1ED63B-8414-4146-A96D-24A852F2FB8E

P356

Q28284294-D444BF75-90DB-4B95-B04C-7201B211C8CE

P407

Q28284294-FE74490D-80B8-458D-AFD0-68E6A59E6599

P433

Q28284294-8188B93F-3DBA-4616-A956-71CE2FCB2AAC

P478

Q28284294-1C440CFA-8FD0-4F54-95E8-FDE41A1018BB

P577

Q28284294-4D10B50E-52B6-41FF-A13C-0CF3390D89F2

P698

Q28284294-F044B959-66D1-4062-AFD9-9E8442D6FAA8

P3181

P356

P1433

Biochemical and Biophysical Research Communications

P1476

Molecular cloning, expression ...... receptors gamma 1 and gamma 2

@en

P2093

A Elbrecht

http://www.w3.org/2001/XMLSchema#string

C A Cullinan

http://www.w3.org/2001/XMLSchema#string

D E Moller

http://www.w3.org/2001/XMLSchema#string

J Berger

http://www.w3.org/2001/XMLSchema#string

M d Leibowitz

http://www.w3.org/2001/XMLSchema#string

N Hayes

http://www.w3.org/2001/XMLSchema#string

Y Chen

http://www.w3.org/2001/XMLSchema#string

P304

431-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

465255

http://www.w3.org/2001/XMLSchema#string

P356

10.1006/BBRC.1996.1044

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

224

http://www.w3.org/2001/XMLSchema#string

P577

1996-07-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8702406

http://www.w3.org/2001/XMLSchema#string